NDC 72189-417 – Allopurinol
Allopurinol 300 mg/1 · Tablet · Oral
Product NDC72189-417
Product details
- Brand name
- Allopurinol
- Generic name
- Allopurinol
- Labeler
- Direct_Rx
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA204467
- Marketed since
- February 2, 2023
- Marketing end
- October 31, 2029
- Pharmacologic class
- Xanthine Oxidase Inhibitor
Active ingredients
- Allopurinol 300 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72189-417-30 | 30 TABLET in 1 BOTTLE (72189-417-30) | Feb 2, 2023 |
| 72189-417-90 | 90 TABLET in 1 BOTTLE (72189-417-90) | Feb 2, 2023 |
Other Allopurinol products
- 50090-7351 Allopurinol 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-6968 Allopurinol 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-7697 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-7696 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-7791 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-6716 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-6882 Allopurinol 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-7353 Allopurinol 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-4662 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-4663 Allopurinol 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-6715 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-5168 Allopurinol 100 mg/1 · Tablet · A-S Medication Solutions